Hemodynamic effects of 5-aminolevulinic acid in humans.
暂无分享,去创建一个
D. Kessel | D Kessel | M A Herman | J Webber | D Fromm | J. Webber | M. Herman | D. Fromm | Mark A. Herman | David Kessel | David Fromm
[1] P. Meissner,et al. The acute porphyrias , 1997, The Lancet.
[2] D. Kessel,et al. Side effects and photosensitization of human tissues after aminolevulinic acid. , 1997, The Journal of surgical research.
[3] Q. Peng,et al. 5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.
[4] J Moan,et al. DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA , 1995, Photochemistry and photobiology.
[5] N. F. Jensen,et al. Anesthetic Considerations in Porphyrias , 1995, Anesthesia and analgesia.
[6] A Gorchein,et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study. , 1995, Gut.
[7] P. Speight,et al. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid , 1993, The Lancet.
[8] J Moan,et al. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5‐aminolevulinic acid in mice bearing mammary carcinoma , 1992, International journal of cancer.
[9] J C Kennedy,et al. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.
[10] A Gorchein,et al. Sustained high plasma 5‐aminolaevulinic acid concentration in a volunteer: no porphyric symptoms , 1992, European journal of clinical investigation.
[11] S H Snyder,et al. The peripheral‐type benzodiazepine receptor: a protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] S H Snyder,et al. Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. Basbaum,et al. Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: Anatomical and subcellular distribution , 1987, Brain Research Bulletin.
[14] G. Le Fur,et al. Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation. , 1984, Life sciences.
[15] M. Desban,et al. Autoradiographic localization of peripheral benzodiazepine binding sites in the cat brain with [3H]PK 11195 , 1984, Brain Research Bulletin.
[16] D. Douer,et al. Treatment of acute intermittent porphyria with large doses of propranolol. , 1978, JAMA.
[17] M. Beal,et al. Catecholamine uptake, accumulation, and release in acute porphyria. , 1977, The Journal of clinical investigation.
[18] N. Schoenfeld,et al. The effect of beta-adrenergic blocking agents on experimental porphyria induced by 3,5-diethoxycarbonyl-1,4-dihydrocollindine (DDC) in vivo and in vitro , 1976 .
[19] C. Magnussen,et al. Acute intermittent porphyria: clinical and selected research aspects. , 1975, Annals of internal medicine.
[20] H. Bonkowsky,et al. Letter: Hazard of propranolol in treatment of acute prophyria. , 1974, British medical journal.
[21] R. Ward,et al. Acute Intermittent Porphyria: Response of Tachycardia and Hypertension to Propranolol , 1973, British medical journal.
[22] D. Tschudy,et al. ACUTE INTERMITTENT PORPHYRIA: A Clinical and Biochemical Study of 46 Patients , 1970, Medicine.
[23] A. Neuberger,et al. The metabolism of δ-aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N , 1956 .
[24] E G Hahn,et al. Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. , 1995, Gastrointestinal Endoscopy.
[25] S. Snyder,et al. Peripheral type benzodiazepine receptors. , 1989, Annual review of pharmacology and toxicology.